{"url_path":"/sec/pvct/10-q/2026/item-1a","section_key":"item-1a","section_title":"Item 1A RISK FACTORS.**","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-14","source_url":"https://www.sec.gov/Archives/edgar/data/315545/0001493152-26-022950-index.html","accession_number":"0001493152-26-022950","cik":"0000315545","ticker":"PVCT","issuer_name":"PROVECTUS BIOPHARMACEUTICALS, INC.","edgar_url":"https://www.sec.gov/Archives/edgar/data/315545/0001493152-26-022950-index.html","primary_entity_key":"0000315545","primary_entity_name":"PROVECTUS BIOPHARMACEUTICALS, INC."},"word_count":175,"has_tables":true,"body_markdown":"**ITEM\n1A. RISK FACTORS.**\n\n \n\nExcept\nas noted below, there have been no material changes to the risk factors disclosed in our Annual Report on Form 10-K for the year ended\nDecember 31, 2025.\n\n \n\nThe\nfollowing risk factor is provided as an update to our previously disclosed risk factors:\n\n \n\n**Changes\nin U.S. Trade Policies and Other Geopolitical Events Could Adversely Affect Our Operations**\n\n \n\nOngoing\nuncertainty around U.S. trade policies, tariffs, and international agreements may impact the cost and availability of materials, supplies,\nand equipment used in our operations or those of our partners. Any disruptions or increased costs resulting from these changes could\nnegatively affect our business, financial condition, results of operations, and the market price of our common stock.\n\n \n\nIn addition, ongoing international conflicts (including\nmilitary conflicts between Russia and Ukraine and in the Middle East) have created volatility in the global capital markets and may have\nfurther global economic consequences, including disruptions of the supply chain. Any such volatility and disruptions may adversely affect\nour business or the third parties on whom we rely."}